Who owns ISIS Pharmaceuticals?

Key details on ISIS Pharmaceuticals (Ticker: ISIS)

Who owns ISIS Pharmaceuticals?

Is ISIS a good stock to own? Find out who bought ISIS Pharmaceuticals, who sold ISIS Pharmaceuticals (ISIS) stock, and who holds a large position in ISIS Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 16.96M $675.60M Dec. 31, 2013
Artisan Partners Limited Partnership 10.78M $429.32M Dec. 31, 2013
Vanguard 7.68M $306.05M Dec. 31, 2013
ClearBridge Advisors 7.20M $286.75M Dec. 31, 2013
BB Biotech AG 6.42M $255.68M Dec. 31, 2013
Columbia Wanger Asset Management 5.08M $71.52M Sept. 30, 2012
Waddell & Reed Financial 4.74M $188.87M Dec. 31, 2013
BlackRock Fund Advisors 4.21M $167.64M Dec. 31, 2013
STATE STREET CORPORATION 3.49M $36.53M Dec. 31, 2013
T. Rowe Price Associates 3.35M $133.44M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 3.09M $123.18M Dec. 31, 2013
BVF 2.16M $25.94M June 30, 2012
Gail Mannix 2.02M $80.33M Dec. 31, 2013
Jennison Associates 1.91M $75.99M Dec. 31, 2013
Franklin Resources 1.74M $69.19M Dec. 31, 2013
NORTHERN TRUST 1.67M $66.34M Dec. 31, 2013
Tocqueville Asset Management 1.66M $66.13M Dec. 31, 2013
SUSQUEHANNA INTERNATIONAL 1.57M $62.58M Dec. 31, 2013
LORD, ABBETT & CO 1.36M $54.23M Dec. 31, 2013
BlackRock Advisors 1.33M $49.86M Sept. 30, 2013
Damian Sousa 1.32M $52.61M Dec. 31, 2013
Sectoral Asset Management 1.22M $48.70M Dec. 31, 2013
Wells Fargo & Company 1.22M $32.70M June 30, 2013
William Harris Investors 1.16M $8.39M Dec. 31, 2011
ALLIANCEBERNSTEIN 1.12M $44.45M Dec. 31, 2013

Who sold ISIS Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Millennium Management Sept. 30, 2011 1.18M $7.97M
GRANAHAN INVESTMENT MANAGEMENT INC/MA June 30, 2011 1.48M $13.54M